Malaysia will decide whether to proceed with using the AstraZeneca vaccine for the National Covid-19 Immunisation Programme after getting the European Medicines Agency’s (EMA) findings on the vaccine. Coordinating Minister for the Immunisation Programme Khairy Jamaluddin said the report by the European Union agency will determine whether there is a causal link between the use of the vaccine and thrombosis or blood clots.
